Oral contraceptive use and risk of breast carcinoma in situ.

نویسندگان

  • Hazel B Nichols
  • Amy Trentham-Dietz
  • Kathleen M Egan
  • Linda Titus-Ernstoff
  • John M Hampton
  • Polly A Newcomb
چکیده

There is some indication that oral contraceptive use may be associated with a small increase in risk of invasive breast cancer; however, oral contraceptive use in relation to breast carcinoma in situ (BCIS) has rarely been studied. We investigated oral contraceptive use in relation to risk of BCIS in a large population-based case-control study. Female residents of Wisconsin, Massachusetts, and New Hampshire aged 20 to 74 years with a new diagnosis of BCIS (n=1,878) were identified from statewide tumor registries in 1997 to 2001. Age-matched female controls (n=8,041) were randomly selected from population lists. Information on oral contraceptive use and other risk factors was collected during structured telephone interviews. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using logistic regression. In multivariate models, ever use of oral contraceptives was associated with a small and marginally significant increase in BCIS overall (OR, 1.11; 95% CI, 0.99-1.25) and for ductal carcinoma in situ (OR, 1.15; 95% CI, 1.01-1.31). No strong associations were detected according to age started, duration, time since first or last use, or oral contraceptive use relative to the first full-term pregnancy. The slightly increased risk of BCIS seemed limited to former users (OR, 1.13; 95% CI, 1.00-1.27) and women without a family history of breast cancer (OR, 1.16; 95% CI, 1.01-1.32 for ever versus never use). Consistent with invasive breast cancer, these results suggest that oral contraceptive use is at most a minor contributor to BCIS risk.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

بررسی ارتباط روشهای رایج پیشگیری از بارداری با سرطان مهاجم سرویکس

Background and Aim: Invasive cervical carcinoma is one of the most common malignancies in women. The risk factors are old age, low socioeconomic status, multiparity, first intercourse in low age, multipartner, history of infection and sexual transmitted disease (STD), smoking, long term use of oral contraceptive (OCP), malnutrition, and so on. There has been a possible relationship between inva...

متن کامل

Evaluation of cerebral venous thrombosis risk following oral contraceptive use: A case report and update.

Background and Objectives: The aim of the present study was to report a case of cerebral venous thrombosis (CVT) folowing consumption of the oral contraceptive pills with high estrogen levels. Case Report: A 35-year-old woman presenting a headache was diagnosed with thrombosis in the upper sagittal, sigmoid and transverse  veins, by CT SCAN, MRI and MRV of the brain. Conclusion: The chance ...

متن کامل

Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.

Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted a systematic review to estimate associations between oral contraceptive use and breast, cervical, colorectal, and endometrial cancer incidence. We searched PubMed, Embase, and Cochrane Database of Systematic Reviews...

متن کامل

Breast carcinoma in situ: risk factors and screening patterns.

BACKGROUND Risk factors associated with invasive breast cancer are well documented, but those associated with breast carcinoma in situ are not well defined. METHODS We conducted a population-based, case-control study among female residents of Connecticut to identify risk factors for breast carcinoma in situ. Case patients, diagnosed with ductal carcinoma in situ (DCIS) (n = 875) or lobular ca...

متن کامل

l Contraceptive Use and Estrogen / Progesterone eptor – Negative Breast Cancer among B & P can American Women

Downlo kground: Oral contraceptive formulations have changed over time, making it relevant to assess the of more recent formulations on breast cancer risk. In addition, some studies have found stronger posisociations of oral contraceptive use with estrogen receptor–negative (ER) than with ER-positive (ER) cancer. We carried out the first assessment of the effect of oral contraceptive use on the...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

دوره 16 11  شماره 

صفحات  -

تاریخ انتشار 2007